Table 1.
Key demographic and clinical characteristics of 179 patients with localized NB >18 months
| Characteristic | No. | % |
|---|---|---|
| Sex | ||
| male | 86 | 48.0 |
| female | 93 | 52.0 |
| Primary tumor site | ||
| Neck | 4 | 2.2 |
| Chest | 38 | 21.2 |
| Abdomen | 47 | 26.3 |
| Adrenal | 80 | 44.7 |
| Pelvis | 7 | 3.9 |
| combined | 3 | 1.7 |
| MYCN status | ||
| non-amplified | 140 | 78.2 |
| amplified | 36 | 20.1 |
| not available | 3 | 1.7 |
| INSS stage | ||
| stage 1 | 68 | 38.0 |
| stage 2 | 46 | 25.7 |
| stage 3 | 65 | 36.3 |
| NB97 risk group | ||
| low | 96 | 53.6 |
| standard | 36 | 20.1 |
| high | 47 | 26.1 |
| IDRF | ||
| yes | 70 | 39.1 |
| no | 73 | 40.8 |
| not available | 36 | 20.1 |
| INRG risk group | ||
| very low | 88 | 49.2 |
| low | 4 | 2.2 |
| intermediate | 23 | 12.8 |
| high | 36 | 20.1 |
| not available | 28 | 15.6 |
| First operation | ||
| biopsy only | 69 | 38.5 |
| incomplete resection | 13 | 7.3 |
| gross total resection | 14 | 7.8 |
| complete resection | 83 | 46.4 |
| Last operation | ||
| biopsy only | 0 | 0 |
| incomplete resection | 17 | 9.5 |
| gross total resection | 20 | 11.2 |
| complete resection | 40 | 22.3 |
| Best operation | ||
| biopsy only | 1 | 0.6 |
| incomplete resection | 25 | 14.0 |
| gross total resection | 30 | 16.8 |
| complete resection | 123 | 68.7 |
| Chemotherapy | ||
| yes | 82 | 45.8 |
| no | 97 | 54.2 |
| RT of primary tumor site | ||
| yes | 7 | 3.9 |
| no | 172 | 96.1 |
| myeloablative Chemo with ASCT | ||
| yes | 23 | 12.8 |
| no | 156 | 87.2 |